Rapport Therapeutics (RAPP) Tax Provisions (2023)

Rapport Therapeutics (RAPP) posted quarterly Tax Provisions of $6000.0 for Q4 2023, up 500.0% quarter-over-quarter from $1000.0 in Q3 2023.

Analysis

Rapport Therapeutics (RAPP) Tax Provisions (2023) Analysis & Trends

Rapport Therapeutics (RAPP) has reported Tax Provisions for 1 consecutive years, with $6000.0 the latest figure, recorded in Q4 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.62 Bn	131.77 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.73 Bn	77.73 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	63.53 Bn	58.35 Bn	1.37 Bn	-59.00 Mn
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn	15.00 Mn
5	Revolution Medicines	44.05 Bn	44.05 Bn	-	-
6	BeOne Medicines	40.03 Bn	34.93 Bn	1.53 Bn	75.45 Mn
7	Alnylam Pharmaceuticals	35.50 Bn	32.19 Bn	992.69 Mn	13.31 Mn
8	Royalty Pharma	28.52 Bn	27.68 Bn	-	-
9	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	1.90 Mn
10	Rapport Therapeutics	2.23 Bn	2.23 Bn	-	-

Historic Data

Download Data